SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy?
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Dauntless who wrote (1128)12/19/1997 7:14:00 PM
From: Bill Wexler  Read Replies (3) of 7041
 
<<Maybe those companies were accurately described by Ascencio. The point is that the report he issued on Zonagen was filed by omissions, fabrications & false accusations.>>

And why is Zonagen different this time? Is it because you own it? Did Mr. Asensio suddenly decide, "Gee, let's ruin my company's and my personal reputation by issuing a phony writeup on Zoangen...just to piss off the shills on SI."

Results speak for themselves. So far I have seen the following:

1) FACT - Zonagen has not produced a unique drug.

2) FACT - Zonagen has not filed an NDA.

3) FACT - Zonagen results from its clinical trials have been obfuscated and show no conclusive evidence of efficacy.

4) FACT - Zonagen's patent is worthless for the oral administration of phentolamine mesylate.

5) FACT - Zonagen has now lost over $50 million.

6) FACT - Zonagen's stock price has dropped 50% in the course of a few weeks on heavy volume.

7) FACT - Zonagen has hired paid shills and touts to write misleading research reports.

8) FACT - Zonagen has a long history of selling stock but not delivering revenues.

9) FACT - Zonagen announced a dubious stock buyback for $10,000,000 even though they are a cash-burning development stage company with no revenues.

10) OPINION - Zonagen is a scam stock.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News